Comments on:

FDA warns pregnant women of migraine drug risk

Back to the article » |
WASHINGTON (AP) — U.S. health regulators are warning doctors and women of child-bearing age that half-a-dozen medications used to treat migraine headaches can decrease children's intelligence if taken while their mothers are pregnant. The Food and Drug Administration said Monday that the drugs, including Depakote and Depacon, should never be taken by pregnant women for the prevention of...

To learn more about commenting on and our community guidelines, please see our comments FAQ.